Cumberland Pharmaceuticals Reports Third Quarter 2021 Financial Results & Company Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Cumberland Pharmaceuticals (CPIX) Reports Q3 Loss of $0.07/sh
November 9, 2021 5:20 PM ESTCumberland Pharmaceuticals (NASDAQ: CPIX) reported Q3 EPS of ($0.07), versus ($0.03) reported last year. Revenue for the quarter came in at $8.1 million, versus $9.25 million reported last year.
For earnings history and earnings-related data on Cumberland Pharmaceuticals (CPIX) click here.
... More